VEGFA and osteosarcoma: In addition, two independent studies compared VEGF secretion and non-metastatic osteosarcoma proliferation by clinical observation on patients, and suggested that poor prognosis and high local recurrences can be associated with boosted VEGF secretion [86, 87].